The new US Senate bill requiring US stock exchange-listed Chinese companies to certify they are not owned or controlled by China's government is bad for SinoPharm Group (SHTDF) (SHTDY). SinoPharm's own website clearly states it is directly under China's state-owned Assets Supervision and Administration Commission of the State Council or SASAC. China's state's majority ownership over SinoPharm Group was also highlighted when it did its IPO in 2009.
SinoPharm stock's 3-year performance of -44.71% will only worsen because of this new political headwind. Investors now are scared of Pres. Trump's increasingly